Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies

Clinical trial NCT07338604 · RECRUITING

Trial details

NCT number: NCT07338604
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hematolymphoid Malignancies

Start date: 2025-12-12
Primary completion: 2027-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.